Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome

Magnhild L. Kolsgaard Department of Pediatrics, Oslo University Hospital, UllevaalCorrespondence[email protected]

Teresia Wangensteen Department of Medical Genetics, Oslo University Hospital, Ullevaal; Institute of Medical Genetics, University of Oslo

Cathrine Brunborg Centre for Clinical Research, Unit of Epidemiology and Biostatistics, Oslo University Hospital, Ullevaal

Geir Joner Department of Pediatrics, Oslo University Hospital, Ullevaal; Institute of Health Management and Health Economics, University of Oslo

Kirsten B. Holven Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo

Bente Halvorsen Research Institute for Internal Medicine, Oslo University Hospital, Rikshospitalet, University of Oslo

Pål Aukrust Research Institute for Internal Medicine, Oslo University Hospital, Rikshospitalet, University of Oslo; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Rikshospitalet

Serena Tonstad Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo; Department of Preventive Cardiology, Oslo University Hospital, Ullevaal, Oslo, Norway

show all

Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date